Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -12.07%8.8B | ---- | 10.53%10.01B | ---- | -20.55%9.05B | ---- | 19.20%11.39B | ---- | 8.11%9.56B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -23.81%-234M | ---- | 1.56%-189M | ---- | 4.00%-192M | ---- | 1.96%-200M | ---- | -2.00%-204M |
| Dividend (income)- adjustment | ---- | 1.43%-138M | ---- | -6.87%-140M | ---- | 35.47%-131M | ---- | -174.32%-203M | ---- | 49.32%-74M |
| Attributable subsidiary (profit) loss | ---- | -90.79%-912M | ---- | -1,812.00%-478M | ---- | 96.42%-25M | ---- | 10.61%-699M | ---- | 10.42%-782M |
| Impairment and provisions: | ---- | 3.39%488M | ---- | 24.54%472M | ---- | 136.88%379M | ---- | -19.60%160M | ---- | 352.27%199M |
| -Impairment of property, plant and equipment (reversal) | ---- | -25.63%119M | ---- | 66.67%160M | ---- | 159.46%96M | ---- | -47.14%37M | ---- | --70M |
| -Impairment of goodwill | ---- | ---- | ---- | --16M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 24.66%369M | ---- | 4.59%296M | ---- | 130.08%283M | ---- | -4.65%123M | ---- | --129M |
| Revaluation surplus: | ---- | 105.53%51M | ---- | -2,106.52%-923M | ---- | 104.94%46M | ---- | -1,762.00%-931M | ---- | 94.66%-50M |
| -Fair value of investment properties (increase) | ---- | 60.00%16M | ---- | -54.55%10M | ---- | 266.67%22M | ---- | -14.29%6M | ---- | 216.67%7M |
| -Derivative financial instruments fair value (increase) | ---- | 116.11%145M | ---- | -2,207.69%-900M | ---- | 96.02%-39M | ---- | -860.78%-980M | ---- | 88.85%-102M |
| -Other fair value changes | ---- | -233.33%-110M | ---- | -152.38%-33M | ---- | 46.51%63M | ---- | -4.44%43M | ---- | 381.25%45M |
| Asset sale loss (gain): | ---- | -72.26%43M | ---- | 26.02%155M | ---- | 461.76%123M | ---- | -120.24%-34M | ---- | 166.67%168M |
| -Loss (gain) from sale of subsidiary company | ---- | -140.59%-41M | ---- | 1,022.22%101M | ---- | 118.00%9M | ---- | -180.65%-50M | ---- | 244.44%62M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 39.06%89M | ---- | -50.00%64M | ---- | 392.31%128M | ---- | -79.69%26M | ---- | 66.23%128M |
| -Loss (gain) from selling other assets | ---- | 50.00%-5M | ---- | 28.57%-10M | ---- | -40.00%-14M | ---- | 54.55%-10M | ---- | 31.25%-22M |
| Depreciation and amortization: | ---- | 9.37%3.11B | ---- | 9.10%2.84B | ---- | 15.02%2.6B | ---- | 8.75%2.26B | ---- | 16.65%2.08B |
| -Amortization of intangible assets | ---- | -0.76%392M | ---- | 11.27%395M | ---- | 9.57%355M | ---- | 6.58%324M | ---- | 27.73%304M |
| Financial expense | ---- | -6.74%733M | ---- | 16.96%786M | ---- | 16.67%672M | ---- | -5.42%576M | ---- | -16.23%609M |
| Exchange Loss (gain) | ---- | -0.47%210M | ---- | -78.96%211M | ---- | 568.69%1B | ---- | 61.30%-214M | ---- | -385.05%-553M |
| Special items | ---- | 22.12%-162M | ---- | -2,700.00%-208M | ---- | -85.96%8M | ---- | -27.85%57M | ---- | 33.90%79M |
| Operating profit before the change of operating capital | ---- | -4.38%11.98B | ---- | -7.44%12.53B | ---- | 11.26%13.54B | ---- | 10.31%12.17B | ---- | 15.44%11.03B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 400.00%168M | ---- | 72.14%-56M | ---- | 14.10%-201M | ---- | -100.00%-234M | ---- | -154.17%-117M |
| Accounts receivable (increase)decrease | ---- | 326.50%829M | ---- | 16.82%-366M | ---- | 72.19%-440M | ---- | -6.39%-1.58B | ---- | -209.34%-1.49B |
| Accounts payable increase (decrease) | ---- | 131.79%1.15B | ---- | 135.55%497M | ---- | -176.94%-1.4B | ---- | 389.76%1.82B | ---- | 329.01%371M |
| Special items for working capital changes | ---- | -210.46%-1.48B | ---- | -186.28%-478M | ---- | 17.87%554M | ---- | -70.75%470M | ---- | -26.11%1.61B |
| Cash from business operations | ---- | 4.28%12.65B | ---- | 0.62%12.13B | ---- | -4.64%12.05B | ---- | 10.82%12.64B | ---- | -13.24%11.41B |
| China income tax paid | ---- | 6.48%-2.35B | ---- | -28.96%-2.52B | ---- | 10.22%-1.95B | ---- | -27.15%-2.17B | ---- | -17.46%-1.71B |
| Special items of business | -19.01%2.65B | ---- | -18.41%3.27B | ---- | 27.20%4B | ---- | -29.66%3.15B | ---- | 39.25%4.47B | ---- |
| Net cash from operations | -19.01%2.65B | 7.10%10.29B | -18.41%3.27B | -4.85%9.61B | 27.20%4B | -3.48%10.1B | -29.66%3.15B | 7.94%10.47B | 39.25%4.47B | -17.06%9.7B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -64.23%49M | 23.81%234M | 55.68%137M | -1.56%189M | -8.33%88M | -4.00%192M | 5.49%96M | -1.96%200M | 22.97%91M | 2.00%204M |
| Dividend received - investment | 3.36%123M | -1.62%547M | 9.17%119M | 21.93%556M | 127.08%109M | -35.14%456M | -69.23%48M | 4.93%703M | 183.64%156M | 2.60%670M |
| Loan receivable (increase) decrease | -30.97%243M | 11.42%800M | 206.09%352M | 803.92%718M | -81.69%115M | 80.97%-102M | 594.49%628M | 59.64%-536M | 81.02%-127M | -263.35%-1.33B |
| Decrease in deposits (increase) | -83.64%27M | 465.22%130M | -41.90%165M | -70.51%23M | 102.86%284M | 135.62%78M | 81.82%140M | -189.02%-219M | -45.00%77M | 179.10%246M |
| Sale of fixed assets | -95.92%2M | 5.47%212M | 1,125.00%49M | -47.66%201M | --4M | 147.74%384M | ---- | -13.41%155M | ---- | -23.50%179M |
| Purchase of fixed assets | -35.88%-3.13B | 4.90%-6.18B | 24.55%-2.31B | -4.07%-6.5B | -23.53%-3.06B | 0.19%-6.24B | 2.18%-2.47B | -13.38%-6.25B | -13.01%-2.53B | 24.16%-5.52B |
| Selling intangible assets | ---- | -54.55%30M | ---- | 112.90%66M | ---- | 10.71%31M | ---- | -9.68%28M | ---- | -73.95%31M |
| Purchase of intangible assets | 60.44%-144M | -13.21%-557M | -161.87%-364M | 26.79%-492M | 33.81%-139M | -363.45%-672M | -813.04%-210M | 5.84%-145M | ---23M | 39.37%-154M |
| Sale of subsidiaries | ---- | 250.00%108M | ---- | -161.02%-72M | ---- | -64.13%118M | ---- | 15.03%329M | -84.85%5M | 236.47%286M |
| Acquisition of subsidiaries | ---- | 20.00%6M | ---- | 106.17%5M | ---- | 88.84%-81M | ---- | -14.15%-726M | 43.54%-166M | 45.87%-636M |
| Recovery of cash from investments | -2.17%6.18B | 30.32%16.13B | 7.98%6.32B | -27.73%12.38B | -40.34%5.85B | 36.68%17.13B | 89.31%9.81B | 19.46%12.53B | -24.50%5.18B | -49.86%10.49B |
| Cash on investment | 0.97%-6.05B | -33.34%-15.9B | -14.26%-6.11B | 29.91%-11.93B | 42.14%-5.34B | -32.60%-17.02B | -76.83%-9.23B | -17.05%-12.83B | 26.90%-5.22B | 47.06%-10.96B |
| Other items in the investment business | -35.82%86M | ---- | 857.14%134M | ---- | 122.22%14M | ---- | -1,475.00%-63M | ---- | 96.64%-4M | ---- |
| Net cash from investment operations | -74.22%-2.61B | 8.48%-4.44B | 27.65%-1.5B | 15.32%-4.85B | -64.73%-2.07B | 15.37%-5.73B | 50.90%-1.26B | -4.24%-6.77B | 22.39%-2.56B | 3.06%-6.49B |
| Net cash before financing | -97.91%37M | 22.95%5.86B | -8.53%1.77B | 8.84%4.76B | 2.27%1.93B | 18.27%4.38B | -1.30%1.89B | 15.44%3.7B | 2,408.43%1.92B | -35.82%3.21B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -62.48%5.85B | -7.31%21.91B | 32.85%15.59B | 2.92%23.64B | 19.06%11.74B | 65.44%22.97B | 110.53%9.86B | -33.17%13.88B | -25.09%4.68B | 109.81%20.77B |
| Refund | 62.11%-6.68B | -16.90%-24.16B | -74.38%-17.64B | 6.13%-20.67B | 3.42%-10.12B | -93.97%-22.02B | -185.16%-10.47B | 54.22%-11.35B | 75.94%-3.67B | -19.29%-24.79B |
| Issuing shares | --1M | ---- | ---- | -58.33%20M | -9.09%20M | -46.67%48M | -63.33%22M | -20.35%90M | 400.00%60M | 117.31%113M |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | --3.58B | --3.58B | ---- | ---- | 142.00%5.07B |
| Interest paid - financing | 32.57%-296M | 7.63%-823M | -10.86%-439M | -9.46%-891M | -16.47%-396M | -18.66%-814M | 11.92%-340M | 9.26%-686M | 6.99%-386M | 6.20%-756M |
| Dividends paid - financing | -1.30%-390M | 3.42%-3.72B | 11.49%-385M | -16.07%-3.86B | -52.63%-435M | 7.05%-3.32B | 20.17%-285M | -54.85%-3.57B | -40.00%-357M | -33.03%-2.31B |
| Absorb investment income | -86.90%11M | 74.29%122M | 50.00%84M | -22.22%70M | 80.65%56M | 76.47%90M | 342.86%31M | -47.42%51M | -84.09%7M | -31.69%97M |
| Issuance expenses and redemption of securities expenses | ---- | 26.42%-1.05B | ---284M | 75.66%-1.43B | ---- | -144.35%-5.88B | 36.80%-1.5B | -1,056.73%-2.41B | ---2.37B | 92.97%-208M |
| Other items of the financing business | 196.61%228M | -62.93%43M | -316.51%-236M | -72.64%116M | 22.47%109M | -7.02%424M | -55.94%89M | 101.77%456M | -98.04%202M | -97.39%226M |
| Net cash from financing operations | 59.11%-1.39B | -150.02%-7.86B | -470.71%-3.39B | 37.40%-3.14B | -2.35%915M | -38.09%-5.02B | 149.52%937M | -91.27%-3.64B | -393.79%-1.89B | 65.73%-1.9B |
| Effect of rate | -180.00%-4M | -53.85%6M | -84.85%5M | -23.53%13M | -45.90%33M | 270.00%17M | 2,133.33%61M | 78.72%-10M | -175.00%-3M | -1,666.67%-47M |
| Net Cash | 16.82%-1.35B | -223.58%-2B | -156.97%-1.62B | 351.16%1.62B | 0.74%2.85B | -1,107.81%-645M | 11,683.33%2.83B | -95.09%64M | -95.72%24M | 335.80%1.3B |
| Begining period cash | -20.60%7.69B | 20.27%9.69B | 20.27%9.69B | -7.23%8.06B | -7.23%8.06B | 0.63%8.68B | 0.63%8.68B | 17.05%8.63B | 17.05%8.63B | -6.94%7.37B |
| Cash at the end | -21.46%6.34B | -20.60%7.69B | -26.21%8.07B | 20.27%9.69B | -5.49%10.94B | -7.23%8.06B | 33.78%11.57B | 0.63%8.68B | 8.98%8.65B | 17.05%8.63B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.